SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017174
Filing Date
2019-05-08
Accepted
2019-05-08 16:02:26
Documents
49
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cbay-10q_20190331.htm 10-Q 1837306
2 EX-31.1 cbay-ex311_9.htm EX-31.1 15430
3 EX-31.2 cbay-ex312_7.htm EX-31.2 15333
4 EX-32.1 cbay-ex321_6.htm EX-32.1 8005
  Complete submission text file 0001564590-19-017174.txt   6506303

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cbay-20190331.xml EX-101.INS 1688596
6 XBRL TAXONOMY EXTENSION SCHEMA cbay-20190331.xsd EX-101.SCH 33848
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbay-20190331_cal.xml EX-101.CAL 44412
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbay-20190331_def.xml EX-101.DEF 77325
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbay-20190331_lab.xml EX-101.LAB 268323
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbay-20190331_pre.xml EX-101.PRE 193174
Mailing Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560
Business Address 7575 GATEWAY BOULEVARD SUITE 110 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36500 | Film No.: 19806565
SIC: 2834 Pharmaceutical Preparations